[{"Assets_0_Q2_USD":"1081486000.0","CIK":"1743881","CommonStockSharesConverted_0_Q2_shares":"152894108.0","CommonStockSharesOutstanding_0_Q2_shares":"149614740.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.66","EarningsPerShareBasic_2_Q2_USD":"-1.82","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q2_USD":"6804000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-242478000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"-96348000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"-259427000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q2_USD":"-102074000.0","ProfitLoss_2_Q2_USD":"-273156000.0","RevenuesConverted_1_Q2_USD":"54024000.0","RevenuesConverted_2_Q2_USD":"54486000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"-457490000.0","StockholdersEquity_0_Q2_USD":"-464294000.0","Ticker":"BBIO","filed":"20210805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"BRIDGEBIO PHARMA, INC.","period":"20210630","qtrs":"0","uom":"USD"}]